- Laboratory
- Laboratory medicine
- Solution reagent
- Randox Laboratories
- Products
- Catalogs
- News & Trends
- Exhibitions
EQA reagent RQ9111solutionfor therapeutic drug monitoringlyophilized
Add to favorites
Compare this product
Characteristics
- Type
- solution
- Applications
- for EQA, for therapeutic drug monitoring
- Format
- lyophilized
- Tested parameter
- for drugs
Description
The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
Accredited to ISO/IEC 17043
Lyophilised for enhanced stability
100% human serum
Bi-weekly reporting
Submit results and view reports online via RIQAS.Net
Register up to five instruments at no extra cost
Weighed in values reported for each parameter
Parameters
Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digoxin, Ethosuximide, Gentamicin, Lithium, Methotrexate, Paracetamol, Phenobarbital, Phenytoin, Primidone, Salicylic acid, Theophylline, Tobramycin, Valproic acid and Vancomycin"
Catalogs
Reagents Brochure
72 Pages
Related Searches
- Randox reagent
- Randox test kit
- Randox solution reagent
- Blood assay kit
- Randox molecular biology reagent
- Randox immunoassay test kit
- Randox liquid reagent
- Plasma assay kit
- Randox research reagent
- Randox diagnostic reagent
- Randox laboratory reagent
- Randox protein reagent
- Immunoassay rapid diagnostic test
- Molecular test kit
- Respiratory infection test kit
- Randox enzyme reagent
- Randox rapid virus test
- Whole blood detection kit
- Randox optical test kit
- Randox biochemistry reagent
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.